Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey C Farrell

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Experimental Cell Research|April 15, 2017
Deriving and testing of dysplastic murine hepatocytes: A new platform in liver cancer researchSharon Pok, Harpreet Vohra, Charbel Wehbe, et al.
Journal of Lipid Research|April 14, 2017
Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASHGeorge N Ioannou, Savitha Subramanian, Alan Chait, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivoJun Yu, Liang Qiao, Lars Zimmermann, et al.
Journal of Lipid Research|December 19, 2014
Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASHGeorge N Ioannou, Derrick M Van Rooyen, Christopher Savard, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severityShivakumar Chitturi, Martin Weltman, Geoffrey C Farrell, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis CJason M Hui, James G Kench, Shivakumar Chitturi, et al.
Biochemical and Biophysical Research Communications|March 7, 2006
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant miceTodor Arsov, Claire Z Larter, Christopher J Nolan, et al.
Journal of Gastroenterology and Hepatology|September 18, 2007
Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulationClaire Z Larter, Matthew M Yeh, Jenny Cheng, et al.
Gynecologic Oncology|October 11, 2005
MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinomaAlexander D Guminski, Rosemary L Balleine, Yoke-Eng Chiew, et al.
Journal of Hepatology|April 18, 2020
Exercise retards hepatocarcinogenesis in obese mice independently of weight controlArfianti Arfianti, Sharon Pok, Vanessa Barn, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Experimental Cell Research|April 15, 2017
Deriving and testing of dysplastic murine hepatocytes: A new platform in liver cancer researchSharon Pok, Harpreet Vohra, Charbel Wehbe, et al.
Journal of Lipid Research|April 14, 2017
Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASHGeorge N Ioannou, Savitha Subramanian, Alan Chait, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivoJun Yu, Liang Qiao, Lars Zimmermann, et al.
Journal of Lipid Research|December 19, 2014
Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASHGeorge N Ioannou, Derrick M Van Rooyen, Christopher Savard, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severityShivakumar Chitturi, Martin Weltman, Geoffrey C Farrell, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis CJason M Hui, James G Kench, Shivakumar Chitturi, et al.
Biochemical and Biophysical Research Communications|March 7, 2006
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant miceTodor Arsov, Claire Z Larter, Christopher J Nolan, et al.
Journal of Gastroenterology and Hepatology|September 18, 2007
Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulationClaire Z Larter, Matthew M Yeh, Jenny Cheng, et al.
Gynecologic Oncology|October 11, 2005
MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinomaAlexander D Guminski, Rosemary L Balleine, Yoke-Eng Chiew, et al.
Journal of Hepatology|April 18, 2020
Exercise retards hepatocarcinogenesis in obese mice independently of weight controlArfianti Arfianti, Sharon Pok, Vanessa Barn, et al.
Pageof 13